Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ResMed Inc. (RMD) vs Star Bulk Carriers Corp (SBLK) Price & Performance

ResMed Inc.Trade
Star Bulk Carriers CorpTrade

Price performance (Past 24H)

Key statistics

ResMed Inc. vs Star Bulk Carriers Corp — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.89B), while Star Bulk Carriers Corp trades at $31.1 (market cap $3.46B). The key difference: ResMed Inc. is far larger — about 9.2× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.06%). Which is the better fit depends on your goals.

RMDSBLK
Market Cap
$31.89B$3.46B
Sector
HealthIndustrials
52-Week High
$283.28$32.42
52-Week Low
$182.82$16.79
Enterprise Value
$31.24B$4.14B
Dividend Yield
1.19%6.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ResMed Inc.

ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.

The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.

Star Bulk Carriers Corp

Star Bulk Carriers (SBLK) trades at $31.02, down 4.32% on the day, with strong technical indicators showing a bullish trend. The company demonstrates robust fundamentals with Q2 2026 EPS of $1.21 beating expectations by 27%, maintaining a three-quarter earnings beat streak. Valuation metrics appear reasonable with P/E of 12.16 and P/B of 1.38, while profitability remains strong with 23.87% net income margin. Recent developments include a parallel listing on Euronext Athens and consistent dividend payments.

SBLK presents a compelling investment case with strong earnings momentum, attractive dividend yield, and positive analyst sentiment. However, risks include shipping rate volatility and geopolitical tensions affecting global trade. The stock's current technical strength and fundamental performance suggest potential upside, though investors should monitor industry cyclicality and the company's execution on its growth strategy.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD

About Star Bulk Carriers Corp

Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.

Read more on SBLK